Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006–January 2008

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

2007 • 2,003 citations

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

2007 • 1,829 citations

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

2007 • 1,820 citations

Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

2007 • 1,654 citations

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

2007 • 1,287 citations

Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

2007 • 652 citations

Comparison of the Immunogenicity and Reactogenicity of a Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine in Male and Female Adolescents and Young Adult Women

2006 • 480 citations

Exploring the Knowledge, Attitudes, Beliefs, and Communication Preferences of the General Public Regarding HPV

2007 • 277 citations

Immunization of Early Adolescent Females with Human Papillomavirus Type 16 and 18 L1 Virus-Like Particle Vaccine Containing AS04 Adjuvant

2007 • 236 citations

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

2006 • 235 citations

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

2007 • 160 citations

Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions

2007 • 130 citations

A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program

2007 • 104 citations

Chapter 15: HPV vaccine use in the developing world

2006 • 93 citations

HPV and cervical cancer: screening or vaccination?

2008 • 91 citations

Effect of Alternative Aluminum Adjuvants on the Absorption and Immunogenicity of HPV16 L1 VLPs in Mice

2007 • 80 citations

Chapter 14: HPV vaccine introduction in industrialized countries

2006 • 50 citations

Prevention and control of viral hepatitis through adolescent health programmes in Europe

2007 • 22 citations

Human papillomavirus (HPV) 16/18 l1 AS04 virus-like particle (VLP) cervical cancer vaccine is immunogenic and well-tolerated 18 months after vaccination in women up to age 55 years

2007 • 21 citations

Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines

2006 • 16 citations

Deleted Work

1955 • 0 citations